GAUSH MEDITECH (02407) · Company profile · Eqvero

GAUSH MEDITECH

02407HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.38 bn CNY	1.43 bn CNY	1.41 bn CNY	1.25 bn CNY	1.3 bn CNY
Cost of revenue	664.63 m CNY	692.49 m CNY	645.67 m CNY	566.79 m CNY	636.55 m CNY
Research and development expense	98.92 m CNY	80.54 m CNY	52.88 m CNY	41.09 m CNY	23.51 m CNY
Selling, general and administrative expense	418.98 m CNY	378.36 m CNY	378.21 m CNY	333.94 m CNY	320.99 m CNY
Operating profit after depreciation	112.61 m CNY	171.29 m CNY	253.3 m CNY	54.56 m CNY	243.32 m CNY
Operating profit before depreciation	203.47 m CNY	253.24 m CNY	329.27 m CNY	120.31 m CNY	303.38 m CNY
EBIT	112.61 m CNY	171.29 m CNY	253.3 m CNY	54.56 m CNY	243.32 m CNY
EBITDA	203.47 m CNY	253.24 m CNY	329.27 m CNY	120.31 m CNY	303.38 m CNY
Interest expense	19.59 m CNY	36.71 m CNY	50.61 m CNY	42.68 m CNY	83.53 m CNY
Profit before tax	114.68 m CNY	155.29 m CNY	247.74 m CNY	-275.09 m CNY	-137.96 m CNY
Income tax expense	23.49 m CNY	66.76 m CNY	74.82 m CNY	77.62 m CNY	53.61 m CNY
Income before extraordinary items	96.19 m CNY	92.39 m CNY	173.52 m CNY	-349.62 m CNY	-190.45 m CNY
Common dividends	—	41.69 m CNY	147.75 m CNY	—	—
Total dividends	—	41.69 m CNY	147.75 m CNY	—	—

Quotes are end-of-day data. Content is for research purposes and is not investment advice.